Bryan S.J. Mallindine, President of Flexiciser™, Inc. Nominated as one of the 2009 Most Admired CEO's in San Diego Bryan S.J. Mallindine is one of the finalists selcted for this yearts Most Admired CO's In San Diego, Event is put on by the San Diego Business Journal and will be held in San Diego Nov 18, 2009. (PRWeb Nov 11, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3181244.htm
Source: www.prweb.comBetter Monitoring, Better Prognosis In Liver Disease The latest research in liver disease being presented at Digestive Disease Week® 2009 (DDW®) has important implications for tracking disease development in patients and for current and future transplant recipients. Researchers are making great strides in diagnosing and treating liver disease. "The research being presented during DDW shows how widespread our efforts are in understanding and treating liver disease," said Brent Tetri, MD, Saint Louis University.
Source: www.medicalnewstoday.comHeart Disease Patients Don't Take Their Medicines At least a quarter of people with heart disease don't take vital medicines they have been prescribed to prevent heart attacks and strokes. Results of a study reported at the Royal Pharmaceutical Society's annual event, the British Pharmaceutical Conference in Manchester, confirm that doctors need to pay more attention to the way patients take their medicines, in line with recommendations in recent NICE guidance.
Source: www.medicalnewstoday.comSurviving Sepsis Program -- Increased Compliance Gets Results A 'surviving sepsis' in-hospital project has been shown to improve the care of patients with sepsis. The educational program for early management of patients with septic shock, described in BioMed Central's open access journal Critical Care, increased compliance with sepsis guidelines and led to a 45% risk reduction for in-hospital death. Massimo Girardis led a team of researchers from the University Hospital of Modena who carried out the study.
Source: www.medicalnewstoday.comEffects Of Once-Daily Tadalafil On Erectile Function In Men With Erectile Dysfunction And Signs And Symptoms Of Benign Prostatic Hyperplasia UroToday.com - Men with benign prostatic hyperplasia (BPH) often suffer from lower urinary tract symptoms (LUTS; BPH-LUTS) such as urinary frequency, urgency, intermittency, nocturia, straining, incomplete emptying, or weak urinary stream. BPH-LUTS and erectile dysfunction (ED), both highly prevalent conditions in aging men, are frequently associated in the same men, may have common pathophysiological mechanisms, and contribute negatively to quality of life.
Source: www.medicalnewstoday.comSciele Pharma And Plethora Solutions Announce That PSD502 Demonstrates Substantial Benefit In The Treatment Of Premature Ejaculation Sciele Pharma, Inc. a Shiongi Company, and Plethora Solutions Holdings PLC ("Plethora" - AME:PLE) today presented highly encouraging results from a European Phase III randomized, double-blind, placebo-controlled study of PSD502 for the treatment of premature ejaculation (PE). In this study, men treated with PSD502 five minutes before intercourse were able to delay ejaculation up to six times longer than those who used a placebo.
Source: www.medicalnewstoday.com
# posted by Network @ 3:11 PM
